CNE100004447
CNE100004447
CATHAY BIOTECH INC
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.295.051.930 | 2.957.911.555 | 11.4% |
| Cost of Revenue | 2.167.646.190 | 2.033.666.836 | 6.6% |
| Gross Profit | 1.127.405.740 | 924.244.719 | 22.0% |
| 453.200.851 | 437.484.830 | 3.6% | |
| Operating Income | 674.204.889 | 486.759.889 | 38.5% |
| Pretax Income | 630.164.829 | 548.015.229 | 15.0% |
| Net Income Common Stockholders | 560.720.037 | 488.961.919 | 14.7% |
| -- | -- | -- | |
| -- | -- | -- |